APA aipamena

Nagler, A., Vredevoogd, D. W., Alon, M., Cheng, P. F., Trabish, S., Kalaora, S., . . . Samuels, Y. (2019). A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma. Pigment Cell Melanoma Res.

Chicago Style aipamena

Nagler, Adi, et al. "A Genome‐wide CRISPR Screen Identifies FBXO42 Involvement in Resistance Toward MEK Inhibition in NRAS‐mutant Melanoma." Pigment Cell Melanoma Res 2019.

MLA aipamena

Nagler, Adi, et al. "A Genome‐wide CRISPR Screen Identifies FBXO42 Involvement in Resistance Toward MEK Inhibition in NRAS‐mutant Melanoma." Pigment Cell Melanoma Res 2019.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.